Breast Cancer Trial, By Invitation NCT07376681 Sponsor: Taizhou Hospital Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, By Invitation

NCT07376681
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Female patients who were diagnosed with breast cancer at age 40 or younger.
  • People with breast cancer that has been confirmed through laboratory testing (such as a biopsy), where the cancer is at stage 0, I, II, or III, and the disease is either stable or progressing.
  • People who have complete medical records and follow-up information available, and who have given informed consent to participate.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • Female patients who were diagnosed with breast cancer after the age of 40.
  • People who were diagnosed with stage IV (advanced/spread) breast cancer at the time of their first diagnosis.
  • People who have other reproductive system conditions that cause irregular or absent periods, or infertility (confirm with trial site).
  • People who have incomplete medical records or who have been lost to follow-up.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Taizhou Hospital
Registry
ClinicalTrials.gov
Start date
1 January 2026
Est. completion
1 October 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The overall-surviva(OS) period of childbirth after diagnosis; The disease-free survival(DFS) period of childbirth after diagnosis; The growth and development of offspring; The occurrence of diseases in the descendants of young breast cancer patients.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov